Literature DB >> 26067686

Metformin for pancreatic cancer.

Kyaw L Aung1, Malcolm J Moore2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26067686     DOI： 10.1016/S1470-2045(15)00029-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

1.  The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma.

Authors:  Rui Liu; Qing Wang; Guangying Xu; Kexin Li; Lingli Zhou; Baofeng Xu
Journal:  Tumour Biol       Date:  2015-08-07

2.  CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.

Authors:  Kexin Li; Baofeng Xu; Guangying Xu; Rui Liu
Journal:  Tumour Biol       Date:  2015-07-29

Review 3.  Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.

Authors:  Ping-Ting Zhou; Bo Li; Fu-Rao Liu; Mei-Chao Zhang; Qian Wang; Yan-Yan Li; Ci Xu; Yuan-Hua Liu; Yuan Yao; Dong Li
Journal:  Oncotarget       Date:  2017-04-11

4.  Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study.

Authors:  Yu-Jui Kuo; Fung-Chang Sung; Po-Fan Hsieh; Hui-Ping Chang; Kun-Ling Wu; Hsi-Chin Wu
Journal:  Cancer Med       Date:  2019-04-09       Impact factor: 4.452

5.  Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma.

Authors:  Bo Li; Pingting Zhou; Kehan Xu; Tianrui Chen; Jian Jiao; Haifeng Wei; Xinghai Yang; Wei Xu; Wei Wan; Jianru Xiao
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 10.750

6.  Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.

Authors:  Yingming Sun; Xiaochuan Chen; Yajuan Zhou; Sufang Qiu; Yongyang Wu; Min Xie; Guofang Zhu; Shanshan Liang; Heming Li; Dong Zhou; Zaishuang Ju; Fuguang Wang; Fang Han; Zhe Wang; Ruoyu Wang
Journal:  Int J Med Sci       Date:  2020-09-01       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.